BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,138 filers reported holding BAXTER INTL INC in Q4 2019. The put-call ratio across all filers is 0.53 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $68,649,000 | +17.3% | 852,783 | +22.9% | 0.86% | -0.6% |
| Q1 2021 | $58,508,000 | +3.9% | 693,714 | -1.1% | 0.87% | +0.1% |
| Q4 2020 | $56,291,000 | +20.5% | 701,536 | +20.8% | 0.87% | +1.4% |
| Q3 2020 | $46,703,000 | -1.6% | 580,736 | +5.3% | 0.86% | -7.8% |
| Q2 2020 | $47,479,000 | +26.4% | 551,436 | +19.2% | 0.93% | -6.7% |
| Q1 2020 | $37,558,000 | -16.9% | 462,596 | -14.4% | 1.00% | -1.9% |
| Q4 2019 | $45,196,000 | +28.7% | 540,496 | +34.6% | 1.02% | +3.8% |
| Q3 2019 | $35,119,000 | +4.0% | 401,496 | -2.6% | 0.98% | +18.5% |
| Q2 2019 | $33,767,000 | +5.3% | 412,296 | +4.6% | 0.82% | -1.6% |
| Q1 2019 | $32,060,000 | +16.3% | 394,296 | -5.9% | 0.84% | +1.5% |
| Q4 2018 | $27,578,000 | +0.3% | 418,996 | +17.4% | 0.83% | +8.0% |
| Q3 2018 | $27,505,000 | -1.8% | 356,796 | -5.9% | 0.76% | -2.7% |
| Q2 2018 | $28,007,000 | -4.1% | 379,296 | -15.5% | 0.79% | -9.7% |
| Q1 2018 | $29,190,000 | +0.6% | 448,800 | 0.0% | 0.87% | -0.2% |
| Q4 2017 | $29,010,000 | +8.2% | 448,800 | +5.0% | 0.87% | +8.6% |
| Q3 2017 | $26,819,000 | -6.2% | 427,400 | -9.5% | 0.80% | -10.9% |
| Q2 2017 | $28,581,000 | +24.7% | 472,100 | +6.8% | 0.90% | +19.0% |
| Q1 2017 | $22,917,000 | +16.0% | 441,900 | -0.8% | 0.76% | +6.9% |
| Q4 2016 | $19,749,000 | -9.3% | 445,400 | -2.6% | 0.71% | -11.6% |
| Q3 2016 | $21,767,000 | -3.8% | 457,300 | -8.6% | 0.80% | -15.1% |
| Q2 2016 | $22,628,000 | +22.7% | 500,400 | +11.5% | 0.94% | +4.7% |
| Q1 2016 | $18,441,000 | – | 448,900 | – | 0.90% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |